| Eli Lilly And Company | 1.42M | US$1.71B | 14.3% |
| Johnson & Johnson | 3.12M | US$792M | 6.6% |
| Unitedhealth Group Incorporated | 1.72M | US$716M | 6.0% |
| Abbvie Inc. | 2.42M | US$609M | 5.1% |
| Merck & Company, Inc. | 3.73M | US$479M | 4.0% |
| Gilead Sciences, Inc. | 2.67M | US$337M | 2.8% |
| Thermo Fisher Scientific Inc | 601K | US$301M | 2.5% |
| Vertex Pharmaceuticals Incorporated | 548K | US$272M | 2.3% |
| Bristol-myers Squibb Company | 4.37M | US$252M | 2.1% |
| Abbott Laboratories | 2.48M | US$225M | 1.9% |
| Intuitive Surgical, Inc. | 563K | US$224M | 1.9% |
| Amgen Inc. | 600K | US$217M | 1.8% |
| Stryker Corporation | 676K | US$213M | 1.8% |
| Elevance Health, Inc. | 472K | US$183M | 1.5% |
| Natera, Inc. | 632K | US$172M | 1.4% |
| Danaher Corporation | 894K | US$170M | 1.4% |
| Guardant Health, Inc. | 976K | US$146M | 1.2% |
| Cardinal Health, Inc. | 519K | US$123M | 1.0% |
| Royalty Pharma Plc | 2.06M | US$116M | 0.97% |
| Cvs Health Corporation | 1.08M | US$112M | 0.94% |
| Tenet Healthcare Corporation | 598K | US$112M | 0.94% |
| Kymera Therapeutics, Inc. | 925K | US$106M | 0.89% |
| Protagonist Therapeutics, Inc. | 829K | US$102M | 0.85% |
| Moderna, Inc. | 1.41M | US$98.9M | 0.83% |
| Brightspring Health Services, Inc. | 1.41M | US$98.3M | 0.82% |
| Revolution Medicines, Inc. | 495K | US$92.8M | 0.78% |
| Roivant Sciences Ltd. | 2.37M | US$84M | 0.70% |
| Alnylam Pharmaceuticals, Inc. | 266K | US$80.2M | 0.67% |
| Viatris Inc. | 4.95M | US$78.6M | 0.66% |
| Charles River Laboratories International, Inc. | 326K | US$74M | 0.62% |
| Argenx Se | 76,622 | US$71.1M | 0.60% |
| Edwards Lifesciences Corporation | 780K | US$70.6M | 0.59% |
| Centene Corporation | 1.06M | US$67.9M | 0.57% |
| Spyre Therapeutics, Inc. | 712K | US$63.2M | 0.53% |
| Definium Therapeutics, Inc. | 1.29M | US$60.6M | 0.51% |
| Insmed Incorporated | 548K | US$58.5M | 0.49% |
| Twist Bioscience Corporation | 555K | US$57.1M | 0.48% |
| Chugai Pharmaceutical Co., Ltd. | 1.17M | US$54.1M | 0.45% |
| Astrazeneca Plc | 279K | US$52.9M | 0.44% |
| United Therapeutics Corporation | 96,653 | US$52.4M | 0.44% |
| Krystal Biotech, Inc. | 139K | US$51.6M | 0.43% |
| Boston Scientific Corporation | 1.2M | US$51.1M | 0.43% |
| Medtronic Plc. | 630K | US$49.3M | 0.41% |
| Erasca, Inc. | 2.58M | US$47.3M | 0.40% |
| Billiontoone, Inc. | 378K | US$45.3M | 0.38% |
| Praxis Precision Medicines, Inc. | 133K | US$44.6M | 0.37% |
| Medpace Holdings, Inc. | 84,145 | US$44.6M | 0.37% |
| Monte Rosa Therapeutics, Inc. | 1.82M | US$44.1M | 0.37% |
| Tango Therapeutics, Inc. | 1.4M | US$43.8M | 0.37% |
| Oruka Therapeutics, Inc. | 451K | US$42.9M | 0.36% |
| Ascendis Pharma A/s | 160K | US$42.6M | 0.36% |
| Beone Medicines Ltd. Class A | 153K | US$42.3M | 0.35% |
| Humana Inc. | 106K | US$42.2M | 0.35% |
| Dianthus Therapeutics, Inc. | 429K | US$41.8M | 0.35% |
| Scholar Rock Holding Corporation | 738K | US$40.6M | 0.34% |
| Kodiak Sciences Inc | 1.01M | US$39.5M | 0.33% |
| Axsome Therapeutics, Inc. | 151K | US$37M | 0.31% |
| Summit Therapeutics Inc. | 2.53M | US$36.9M | 0.31% |
| Novo Nordisk A/s Class B | 762K | US$36.1M | 0.30% |
| Regeneron Pharmaceuticals, Inc. | 55,661 | US$34.7M | 0.29% |
| Relay Therapeutics, Inc. | 1.84M | US$34.4M | 0.29% |
| Ionis Pharmaceuticals, Inc. | 434K | US$34.4M | 0.29% |
| Cytokinetics, Incorporated | 395K | US$33.7M | 0.28% |
| Vera Therapeutics, Inc. | 784K | US$33.7M | 0.28% |
| Enliven Therapeutics, Inc. | 647K | US$32.9M | 0.28% |
| Agilent Technologies, Inc. | 245K | US$32.5M | 0.27% |
| Mbx Biosciences, Inc. | 586K | US$32.4M | 0.27% |
| Cg Oncology, Inc. | 438K | US$31.1M | 0.26% |
| Newamsterdam Pharma Company N.v. | 913K | US$30.9M | 0.26% |
| Waters Corporation | 81,880 | US$30.7M | 0.26% |
| Crinetics Pharmaceuticals, Inc. | 813K | US$30.4M | 0.25% |
| Madrigal Pharmaceuticals, Inc. | 56,364 | US$30.3M | 0.25% |
| Liquidia Corporation | 365K | US$29.1M | 0.24% |
| Mirum Pharmaceuticals, Inc. | 248K | US$29M | 0.24% |
| Beam Therapeutics Inc. | 842K | US$28.9M | 0.24% |
| Nurix Therapeutics, Inc. | 1.19M | US$28.8M | 0.24% |
| West Pharmaceutical Services, Inc. | 77,225 | US$27.7M | 0.23% |
| Ideaya Biosciences, Inc. | 727K | US$27.1M | 0.23% |
| Bridgebio Pharma, Inc. | 363K | US$27.1M | 0.23% |
| Teva Pharmaceutical Industries Limited | 795K | US$26.9M | 0.23% |
| Rhythm Pharmaceuticals, Inc. | 242K | US$26.8M | 0.22% |
| Viridian Therapeutics, Inc. | 1.45M | US$26.6M | 0.22% |
| Alkermes Plc | 504K | US$26.4M | 0.22% |
| Alignment Healthcare, Inc. | 1.07M | US$25.4M | 0.21% |
| Vaxcyte, Inc. | 426K | US$24.8M | 0.21% |
| Rapport Therapeutics, Inc. | 572K | US$23.8M | 0.20% |
| Immunome, Inc. | 1.09M | US$23.2M | 0.19% |
| Palvella Therapeutics, Inc. | 144K | US$22M | 0.18% |
| Climb Bio, Inc. | 1.64M | US$21.3M | 0.18% |
| Icon Plc | 120K | US$20.9M | 0.17% |
| Kailera Therapeutics, Inc. | 904K | US$19.9M | 0.17% |
| Celldex Therapeutics, Inc. | 495K | US$18.4M | 0.15% |
| Bicara Therapeutics Inc. | 591K | US$17.5M | 0.15% |
| Cencora, Inc. | 61,157 | US$17.3M | 0.14% |
| Sonova Holding Ag | 72,348 | US$17.2M | 0.14% |
| Alumis Inc. | 595K | US$16.7M | 0.14% |
| Apogee Therapeutics, Inc. | 126K | US$16.7M | 0.14% |
| Oric Pharmaceuticals, Inc. | 1.53M | US$16.6M | 0.14% |
| Veeva Systems Inc. | 91,000 | US$16.1M | 0.14% |
| Moonlake Immunotherapeutics | 792K | US$15.4M | 0.13% |